| 000 | 01862 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518013424.0 | ||
| 264 | 0 | _c20190916 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2018.11.022 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarinka, Cyril | |
| 245 | 0 | 0 |
_aStructural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _c01 2019 |
||
| 300 |
_a255-264 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarbamates _xchemical synthesis |
| 650 | 0 | 4 | _aCatalytic Domain |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDrosophila _xgenetics |
| 650 | 0 | 4 | _aEnzyme Assays |
| 650 | 0 | 4 |
_aGlutamate Carboxypeptidase II _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen Bonding |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aProtease Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aQuantum Theory |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 |
_aUrea _xanalogs & derivatives |
| 700 | 1 | _aNovakova, Zora | |
| 700 | 1 | _aHin, Niyada | |
| 700 | 1 | _aBím, Daniel | |
| 700 | 1 | _aFerraris, Dana V | |
| 700 | 1 | _aDuvall, Bridget | |
| 700 | 1 | _aKabarriti, Gabriel | |
| 700 | 1 | _aTsukamoto, Reiji | |
| 700 | 1 | _aBudesinsky, Milos | |
| 700 | 1 | _aMotlova, Lucia | |
| 700 | 1 | _aRojas, Camilo | |
| 700 | 1 | _aSlusher, Barbara S | |
| 700 | 1 | _aRokob, Tibor András | |
| 700 | 1 | _aRulíšek, Lubomír | |
| 700 | 1 | _aTsukamoto, Takashi | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 27 _gno. 2 _gp. 255-264 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2018.11.022 _zAvailable from publisher's website |
| 999 |
_c29164907 _d29164907 |
||